SHORT MINI-FUTURE - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000VU65FP9

Delayed Deutsche Boerse AG 11:20:38 22/05/2024 pm IST
17.06 EUR +5.83% Intraday chart for SHORT MINI-FUTURE - FRESENIUS MEDICAL CARE
Current month-1.73%
1 month-4.10%
Date Price Change
22/24/22 17.06 +5.83%
21/24/21 16.12 +5.50%
20/24/20 15.28 -0.97%
17/24/17 15.43 -0.26%
16/24/16 15.47 +1.91%

Delayed Quote Deutsche Boerse AG

Last update May 22, 2024 at 11:20 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Vontobel Vontobel
WKN VU65FP
ISINDE000VU65FP9
Date issued 10/05/2023
Strike 55.7
Maturity Unlimited
Parity 1 : 1
Emission price 15.22
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 25.79
Lowest since issue 7.19
Spread 0.12
Spread %0.70%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.75 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.82%
Consensus